Researchers at the University of Illinois at Chicago and Queensland University of Technology of Australia, have developed a device that can isolate individual cancer cells from patient blood samples.
The microfluidic device works by separating the various cell types found in blood by their size. The device may one day enable rapid, cheap liquid biopsies to help detect cancer and develop targeted treatment plans. The findings are reported in the journal Microsystems & Nanoengineering.
“This new microfluidics chip lets us separate cancer cells from whole blood or minimally-diluted blood,” said Ian Papautsky, the Richard and Loan Hill Professor of Bioengineering in the UIC College of Engineering and corresponding author on the paper. “While devices for detecting cancer cells circulating in the blood are becoming available, most are relatively expensive and are out of reach of many research labs or hospitals. Our device is cheap, and doesn’t require much specimen preparation or dilution, making it fast and easy to use.”
The ability to successfully isolate cancer cells is a crucial step in enabling liquid biopsy where cancer could be detected through a simple blood draw. This would eliminate the discomfort and cost of tissue biopsies which use needles or surgical procedures as part of cancer diagnosis. Liquid biopsy could also be useful in tracking the efficacy of chemotherapy over the course of time, and for detecting cancer in organs difficult to access through traditional biopsy techniques, including the brain and lungs.
However, isolating circulating tumor cells from the blood is no easy task, since they are present in extremely small quantities. For many cancers, circulating cells are present at levels close to one per 1 billion blood cells. “A 7.5-milliliter tube of blood, which is a typical volume for a blood draw, might have ten cancer cells and 35-40 billion blood cells,” said Papautsky. “So we are really looking for a needle in a haystack.”
Microfluidic technologies present an alternative to traditional methods of cell detection in fluids. These devices either use markers to capture targeted cells as they float by, or they take advantage of the physical properties of targeted cells — mainly size — to separate them from other cells present in fluids.
Papautsky and his colleagues developed a device that uses size to separate tumor cells from blood. “Using size differences to separate cell types within a fluid is much easier than affinity separation which uses ‘sticky’ tags that capture the right cell type as it goes by,” said Papautsky. “Affinity separation also requires a lot of advanced purification work which size separation techniques don’t need.”
Learn more: New microfluidics device can detect cancer cells in blood
The Latest on: Cancer blood test
[google_news title=”” keyword=”cancer blood test” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer blood test
- Video: How is kidney cancer treated?on March 21, 2023 at 7:15 am
More than 50,000 people in the U.S. are diagnosed with kidney cancer each year. Risks factors for developing this type of cancer include environmental exposures, such as smoking, high blood pressure, ...
- Colon cancer cases rising in younger patientson March 21, 2023 at 6:06 am
No longer can you wait until you are 50 to start worrying about the threat of colon cancer. Colon cancer caught in its earliest stage has a 90% survival rate. After that, the numbers are not so kind.
- Free cancer, cardiac tests offered at Utah County Spring Health Fair and Clinicon March 20, 2023 at 5:58 pm
In February, the country celebrated National Cancer Prevention Month and American Heart Month to bring awareness to the leading causes of death for Americans. These illnesses are preventable and ...
- Blood test looks for early warning signs of colorectal canceron March 20, 2023 at 5:05 pm
A Georgia lab is offering a blood test for colorectal cancer. But, it won't replace the need for a colonoscopy.
- With colon cancer on the rise under age 55, doctors work to boost screeningon March 20, 2023 at 12:32 pm
Doctors noted the trend, and now statistics show colon cancer among those under age 55 has doubled since 1995. So they are working to make patients aware and get them in for the first screening.
- Genetic test can guide treatment for blood cancer to prevent relapseon March 20, 2023 at 10:54 am
Scientists have found a new way to predict which patients with the blood cancer myeloma will benefit the most from a treatment often used to help keep the disease from coming back after a stem cell ...
- Scientists develop breakthrough gene test that can tell if blood cancer medicine will work - as experts call for it to be used as treatment for 6,000 Britons diagnosed with ...on March 20, 2023 at 4:58 am
Scientists have developed a test to identify which blood-cancer patients will benefit the most from a drug that can stop their cancer from returning. The test, which looks for genetic clues in ...
- Woman diagnosed with blood cancer reveals warning signs after doctors insisted: ‘You’re just a busy mum’on March 20, 2023 at 2:00 am
Mum-of-three Donna Hicks, 49, went to her GP complaining of constant fatigue and back pain when her youngest child was one. She had no idea she was suffering from incurable myeloma ...
- Cancer breakthrough for thousands as test could tell if blood cancer medicine will workon March 19, 2023 at 3:08 am
Performed under local anaesthetic, the gene test could help identify patients with myeloma that will benefit from treatment known as lenalidomide.
- Saved by a doping test: The pro rider treated for cancer after abnormal blood resulton March 19, 2023 at 1:00 am
When his team doctor called about an abnormal test result, Torstein Træen could not believe what was happening – but it would turn out to be a potentially life-saving red flag ...
via Bing News